2.48k followers • 15 symbols Watchlist by Motif Investing
Global adoption of minimally invasive procedures could spark new growth. The global minimally invasive surgery market is forecast to reach $35.5 billion by the end of 2016 with compound annual growth rate ("CAGR") of 8.2%.
In the latest trading session, Intuitive Surgical (ISRG) closed at $476.13, marking a +0.49% move from the previous day.
Jana Partners is a New York-based value-oriented and event-driven hedge fund that was launched 18 years ago by Barry Rosenstein. Prior to founding his own investment management firm, Barry Rosenstein honed his investment acumen at private equity fund Sagaponack Partners, at Genesis Merchant Group's Investment and Merchant Banking Group, which he founded as well. Barry […]
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Conmed (CNMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Conmed (CNMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
Results of the study of ExcelsiusGPS reached a milestone for Globus Medical (GMED) in the field of robotics-assisted, minimally invasive pedicle screw placement procedure
Investing to "buy and hold" is trickier than it looks. The increasing pace of technological change means even the most successful, dominant companies have to continually adapt to keep up. Industries like energy, real estate and even consumer products are facing potentially significant long-term changes going forward. In any era, amassing a collection of retirement stocks simply by buying the best companies and holding them for years can be a risky endeavor.General Motors (GM) was a classic "widows and orphans" stock until last decade, when GM wound up going bankrupt. United States Steel (X) once was a pillar of corporate America and a buy-and-hold stock. GM shares basically haven't moved in a quarter of a century. Polaroid and Eastman Kodak were once blue-chip stocks. Both went bankrupt as cameras changed from film to digital.But there still are stocks to buy and hold out there that can last forever, while offering dividend income along the way.Here are ten such retirement stocks to hold forever. SEE ALSO FROM KIPLINGER: 19 Best Retirement Stocks to Buy
Medtronic posted a "solid quarter" on Thursday, one analyst said, though she noted diabetes device revenue only met expectations and cardiac sales lagged estimates from Wall Street analysts.
Check out the companies making headlines midday Thursday:L Brands LB — L Brands surged 12.8% after the parent company of Victoria's Secret and Bath & Body Works reported first-quarter earnings that surpassed expectations .
Medtronic Plc reported quarterly profit ahead of estimates on strong demand for its surgical instruments and forecast better-than-expected 2020 earnings on Thursday, sending shares of the medical device maker up nearly 3%. The company has been building its minimally invasive and robotic surgery device businesses through new launches and acquisitions to ease the impact of rising competition it faces at its top-earning cardiac and vascular unit. There had been growing concerns among investors after the U.S. regulators raised safety concerns about Medtronic's drug-coated balloons, which is part of the company's biggest selling unit, as well as a recent closure of a plant that Medtronic uses to sterilize its surgical instruments.
While pre-market futures are down on a continued souring in trade between the U.S. and China, Jobless Claims, Best Buy and Medtronic brought some good news.
gained on Thursday after the company reported fiscal fourth-quarter earnings that beat analysts' forecasts and offered an upbeat assessment of its prospects for fiscal 2020. Shares of Medtronic gained 2.25% to $90.76 in trading on the New York Stock Exchange after the company reported adjusted net income of $1.94 billion, or $1.42 a share, vs. $1.47 billion, or $1.07 a share, in the comparable year-earlier period. For the full year Medtronic said it earned an adjusted $5.22 a share, above FactSet consensus estimates of $5.15.
Top-line growth and solid show by Subscription services and Professional services units are likely to aid Veeva Systems (VEEV) in Q1 earnings. However, rising expenses remains a dampener.
Excluding the Diabetes group, Medtronic (MDT) displays better performances at CER on the back of growth in rest of the business segments and across all geographies.